Featured by Newsweek & World Class Media Outlets
Sarah Kennedy

Sarah Kennedy

CEO
Calocurb
25 April 2024

How challenging is it to navigate the temptations of the modern world in relation to unhealthy lifestyle choices, and in what ways does your product offer a solution?

Navigating the modern world, filled with endless temptations, especially unhealthy food choices contributing to rising obesity and mental distress levels, presents a considerable challenge.

Our evolutionary biology, which once propelled us to seek food during times of scarcity, now misaligns with our current environment, brimming with accessible, high-calorie foods. This misalignment exacerbates the struggle many face in managing their dietary habits. Calocurb intervenes by targeting the primal part of the brain responsible for food cravings and hunger, helping individuals manage their appetite more effectively. By mitigating the incessant urge to seek out food, our solution fosters a more harmonious relationship between individuals and the plethora of food choices surrounding them, thereby promoting a sense of peace in navigating the modern dietary landscape.

Could you elaborate on the origins, mechanism of action, and ingredients of your product. How does it function to suppress appetite?

The inception of our product traces back to a hypothesis posited by New Zealand scientists, exploring natural extracts capable of suppressing appetite, inspired by historical practices and contemporary pharmaceutical findings. This exploration led to the identification of a specific hop extract as a potent agent in stimulating the release of appetite-suppressing hormones by activating bitter taste receptors throughout the gastrointestinal tract. The rigorous testing process revealed this particular extract's unique ability among thousands to significantly influence the body's natural appetite control mechanisms. Through a specialized capsule, designed to be released below the stomach, this extract leverages evolutionary biological responses to bitter substances, releasing gut hormones that signal the brain to reduce food intake. Published clinical trials have shown a hunger reduction of 30%, craving reduction of 40% and average calorie intake reduction of 18% after one hour thus validating the extract's effectiveness and potential benefits for users seeking a natural way to manage their dietary habits.

Considering the product's efficacy and safety, could you provide insights into consumer experiences and scientific validation?

Our product stands out for its safety and efficacy, rooted in the natural origins of its key ingredient, hops, with a long history of safe consumption in beer. Designed to act predominantly within the gut while minimizing systemic absorption, it offers a targeted approach to appetite suppression This specificity ensures an excellent safety profile, distinguishing our solution in the weight loss industry, often criticized for the adverse effects associated with many products. Anecdotal reports from users affirm its effectiveness in facilitating weight loss and management, corroborated by robust clinical trials that underscore its ability to naturally enhance the body's hormone release for appetite suppression. Our ongoing and future clinical trials aim to solidify this evidence base, ensuring our product not only meets but exceeds expectations for safety and performance in weight management.

What impact does the product have on the gut microbiome, and what are the implications of discontinuing its use?

Current clinical research has not indicated any detrimental effects of our product on the gut microbiome. Its mechanism of action, focused on stimulating taste receptors to trigger hormone release, is designed to be minimally invasive. This aspect is crucial given the growing awareness of the microbiome's role in overall health. Consumer feedback has indicated upon discontinuation, our product does not induce the rebound hunger often associated with other appetite suppressants. Instead, it supports the establishment of healthier eating habits and a rebalanced brain-gut connection, providing a sustainable approach to dietary management without the fear of adverse withdrawal effects. This gentle yet effective mode of action emphasizes our commitment to not only aiding weight management but also ensuring a seamless transition for users wishing to cease supplementation.

Given the product's market reception and strategic future direction, what can you share about growth plans and broader ambitions?

The reception from both the consumer and practitioner markets in the US has been exceptionally positive, affirming our scientific and clinical foundations. Practitioners, in particular, appreciate our product as a safe and effective option post-injection treatment or as an alternative for those unable to tolerate or afford other treatments. This validation has significantly influenced our strategic focus, propelling us toward further scientific exploration rather than diversification. Our future is envisioned as a deep dive into the science underpinning our product, with planned clinical trials on weight management, menopause, and beyond. This approach aligns with our overarching goal of offering a scientifically robust, natural solution to the challenges posed by modern dietary habits, marking a commitment to enhancing human consumption practices through targeted, evidence-based interventions.

As the company contemplates future growth, what reflections do you have on its trajectory and the evolving landscape of dietary supplements?

As we look to the future, Calocurb is poised to redefine the dietary supplement market with its groundbreaking approach, blending pharmaceutical precision with natural efficacy. This fusion of nature and science not only sets Calocurb apart but also primes us for significant expansion, making us an attractive prospect for an increasingly discerning investor base eager to tap into this immense opportunity.